NSEOutcome of Board Meeting6d ago · 2 Nov 2026, 01:37 pm
Outcome of Board Meeting
Eureka Forbes Limited · EUREKAFORB
✦ AI SummaryResults
Eureka Forbes Limited has informed the Exchange regarding Outcome of Board Meeting held on November 02, 2026. The Board has considered and approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with a limited review report. The Board has also re-appointed Mr. Homi Katgara as a non-executive, independent director for a second term.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eureka Forbes Limited has informed the Exchange regarding Outcome of Board Meeting held on November 02, 2026.
Attachments (1)
📄pdf
Download →
SHILPAJAIN_02112026133516_Outcomeofbmrev.pdf
View document text
November 02, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block - G,
Dalal Street, Bandra Kurla Complex,
Mumbai - 400 001 Bandra (East), Mumbai - 400 051
Scrip Code: 543482
Scrip ID: EUREKAFORB Symbol: EUREKAFORB
Ref.: EFL/BSE/2026-27/47 Ref.: EFL/NSE/2026-27/47
Subject : Outcome of the Board Meeting
Dear Sir/Madam,
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) as amended from time
to time, read with Schedule III of the SEBI Listing Regulations and in continuation to our letter
bearing reference nos. EFL/BSE/2026-27/44 and EFL/NSE/2026-27/44 dated October 23, 2026,
we wish to inform that the Board of Directors of the Company at its meeting held today, i.e.,
Monday, November 02, 2026, has inter-alia, has considered and approved the following:
1. Unaudited Standalone and Consolidated Financial Results (“Results”) for the Quarter and Half
Year ended September 30, 2026 along with Limited Review Report (“LRR”) on the Financial
Results issued by the Statutory Auditors of the Company.
A copy of the aforesaid Results along with LRR are attached herewith.
2. Re-appointment of Mr. Homi Katgara (DIN: 00210338) as Non-Executive, Independent
Director of the Company, not liable to retire by rotation, for a second term of 5 (five)
consecutive years commencing from January 31, 2027 to January 30, 2032 (both days
inclusive), subject to the approval of the Members of the Company.
The details with respect to the said Re-appointment and continuation of Directorship, as
required under Regulation 30 read with Part A of Schedule III of SEBI Listing Regulations
read with SEBI Master Circular No. HO/49/14 /14(7)2025-CFD-POD2/I/3762/2026 dated
January 30, 2026, is enclosed as Annexure – 1.
The meeting of the Board of Directors commenced at 12:27 PM IST and concluded at 01:20 PM
IST.
This disclosure is also being uploaded on the Company’s website at: www.eurekaforbes.com.
We request you to take the above on record and disseminate the same on your website(s).
Thanking you,
For Eureka Forbes Limited
Shilpa Jain
Company Secretary & Compliance Officer
Encl: As above
Deloitte Chartered Accountants
Commerz 111, 30th & 31st floors
Haskins & Sells LLP International Business Park
Oberoi Garden City
Off. Western Express Highway
Goregaon (East)
Mumbai-400 063
Maharashtra, India
INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM STANDALONE FINANCIAL
RESULTS
TO THE BOARD OF DIRECTORS OF EUREKA FORBES LIMITED
1. We have reviewed the accompanying Statement of Unaudited Standalone Financial Results of Eureka
Forbes Limited ("the Company") for the quarter and half year ended September 30, 2026 ("the
Statement") being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing
Regulations").
2. This Statement which is the responsibility of the Company's Management and approved by the Company's
Board of Directors, has been prepared in accordance with the recognition and measurement principles laid
down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under
Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting
principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our
responsibility is to express a conclusion on the Statement based on our review.
3. We conducted our review of the Statement in accordance with the Standard on Review Engagements
(SRE) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity',
issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information
consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting
matters and applying analytical and other review procedures. A review is substantially less in scope than
an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the
Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become
aware of all significant matters that might be identified in an audit. Accordingly, we do not express an
audit opinion.
4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that
causes us to believe that the accompanying Statement, prepared in accordance with the recognition and
measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting
principles generally accepted in India, has not disclosed the information required to be disclosed in terms
of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it
contains any material misstatement.
For DELOITTE HASKINS & SELLS LLP
Chartered Accountants
• ' Registration No. 117366W/W-100018)
Nilesh Shah
Partner
Membership No. 049660
Place: Mumbai
UDIN: ze,0l\C\(;G;,o r.. t_ vv t--L 7.._
.l .5/Q
Date: November 02, 2026
Regd. Office: One International Center, Tower 3, 31st floor, Senapati Ba pat Marg, Elphinstone Road (West}, Mumbai-400 013, Maharashtra, India.
Deloitte Haskins & Sells LLP is registered with Limited Liability having LLP identification No: AAB-8737
Eureka Forbes Limited ~- EUREKA
CIN: L27310MH2008PLC188478 I Website: www.eurekaforbes.com uFORBES
Registered/ Corporate Office: B1/B2, 701, 7th Floor, Marathon lnnova, Off Ganpatrao Kadam Marg,
Lower Parel, Mumbai -400 013, Maharashtra, India. Tel: +912248821700/62601888. Friends For Life
Eureka Forbes Limited (CIN-L27310MH2008PLC188478)
Statement of Standalone Unaudited Financial Results for the quarter and half year ended September 30, 2026
fin Lakhs
Quarter ended Half vear ended Year ended
Particulars 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026
Unaudited Unaudited Unaudited Unaudited Unaudited Audited
I Revenue from operations 88,959.13 70,076.74 77,344.93 1,59,035.87 1,38, 119.00 2,71,046.92
II Other income and other gains/(losses) -net 610.90 718.81 586.87 1,329.71 1,300.92 2,316.90
Ill Total income (I + II) 89,570.03 70,795.55 77,931.80 1,60,365.58 1,39,419.92 2,73,363.82
IV Expenses:
Cost of materials consumed 45,476.14 33,281.05 39,942.61 78,757.19 65,869.78 1,11,816.96
Purchases of stock-in-trade 4,978.37 1,768.60 2,167.15 6,746.97 3,852.98 10,910.47
Changes in inventories of finished goods, spares, stock-in-trade and work-in- (10,533.98) (5,908.17) (8,467.61) (16,442.15) (11,602.41) (11,060.64)
progress
SetVice charges 9,564.50 8,344.18 8,482.42 17,908.68 16,606.66 33,180.12
Employee benefits expense 9,761.21 9,659.68 8,576.41 19,420.89 17,277.35 35,003.23
Finance costs 210.16 109.00 224.63 319.16 324.57 783.28
Depreciation and amortisation expense 1,996.21 1,854.33 1,631.92 3,850.54 3,202.12 6,894.70
Other expenses 18,308.60 16,197.05 17,057.92 34,505.65 30,403.26 60,221.79
Total expenses (IV) 79,761.21 65,305.72 69,615.45 1,45,066.93 1,25,934.31 2,47,749.91
V Profit before exceptional items and tax (Ill -IV) 9,808.82 5,489.83 8,316.35 15,298.65 13,485.61 25,613.91
VI Exceptional items -income/(expense) (refer note: 4) - 1,953.77 1,953.77 (4,044.18]
VII Profit before tax (V + VI) 9,808.82 7,443.60 8,316.35 17,252.42 13,485.61 21,569.73
VIII Tax expense:
(a) Income tax 2,578.68 2,020.63 2,297.25 4,599.31 3,653.41 5,681.99
(b) Deferred tax (103.75) (120.66) (139.76) (224.41) (178.88) (132.96:
2,474.93 1,899.97 2,157.49 4,374.90 3,474.53 5,549.03
IX Profit after tax (VII • VIII) 7,333.89 5,543.63 6,158.86 12,877.52 10,011.08 16,020.70
X Other Comprehensive lncome/(Loss)
A Items that will not be reclassified to statement of profit and loss
(i) Remeasurement of the defined benefit plans Gain/(loss) (280.59) (280.59) (114.71) (561.18) (229.43) 701.46
(i
[Showing first 8,000 characters — download PDF for full document]